Shoshana Morecki

3.1k total citations · 1 hit paper
72 papers, 2.4k citations indexed

About

Shoshana Morecki is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Shoshana Morecki has authored 72 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Immunology, 38 papers in Hematology and 16 papers in Oncology. Recurrent topics in Shoshana Morecki's work include Hematopoietic Stem Cell Transplantation (38 papers), Immunotherapy and Immune Responses (28 papers) and Immune Cell Function and Interaction (26 papers). Shoshana Morecki is often cited by papers focused on Hematopoietic Stem Cell Transplantation (38 papers), Immunotherapy and Immune Responses (28 papers) and Immune Cell Function and Interaction (26 papers). Shoshana Morecki collaborates with scholars based in Israel, United States and United Kingdom. Shoshana Morecki's co-authors include Shimon Slavin, Lola Weiss, S Slavin, Yael Gelfand, Memet Aker, Antonella Tabucchi, E. Marinello, Francesca Ficara, Sara Deola and Sergio Vai and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Shoshana Morecki

69 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning

2002 808 citations Shimon Slavin, Shoshana Morecki et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shoshana Morecki Israel	24	1.0k	955	909	777	774	72	2.4k
Charles S. Carter United States	20	1.3k 1.3×	1.1k 1.1×	1.1k 1.2×	513 0.7×	936 1.2×	30	2.9k
R C Moen United States	13	354 0.3×	1.2k 1.3×	1.2k 1.3×	590 0.8×	699 0.9×	20	2.3k
Gwenn Danet-Desnoyers United States	21	1.1k 1.1×	711 0.7×	1.2k 1.3×	598 0.8×	1.6k 2.1×	38	3.1k
Paolo Servida Italy	12	696 0.7×	1.8k 1.8×	1.5k 1.6×	512 0.7×	1.3k 1.7×	17	2.9k
Maria Teresa Lupo Stanghellini Italy	20	998 1.0×	583 0.6×	606 0.7×	777 1.0×	1.5k 1.9×	76	2.5k
Isabelle André‐Schmutz France	27	1.5k 1.5×	907 0.9×	1.1k 1.2×	512 0.7×	481 0.6×	78	3.0k
Sherri W. Christianson United States	11	1.1k 1.1×	857 0.9×	431 0.5×	335 0.4×	427 0.6×	13	2.1k
Stephen D. Lupton United States	15	1.2k 1.2×	673 0.7×	774 0.9×	211 0.3×	776 1.0×	19	2.3k
Patrick Nusbaum France	21	567 0.6×	1.5k 1.5×	1.8k 2.0×	195 0.3×	584 0.8×	34	2.9k
Shuro Yoshida Japan	16	969 1.0×	228 0.2×	669 0.7×	775 1.0×	602 0.8×	67	2.4k

Countries citing papers authored by Shoshana Morecki

Since Specialization

Citations

This map shows the geographic impact of Shoshana Morecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoshana Morecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoshana Morecki more than expected).

Fields of papers citing papers by Shoshana Morecki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoshana Morecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoshana Morecki. The network helps show where Shoshana Morecki may publish in the future.

Co-authorship network of co-authors of Shoshana Morecki

This figure shows the co-authorship network connecting the top 25 collaborators of Shoshana Morecki. A scholar is included among the top collaborators of Shoshana Morecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoshana Morecki. Shoshana Morecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morecki, Shoshana, et al.. (2009). Induction of Graft-versus-Leukemia (GVL) Effect without Graft-versus-Host Disease (GVHD) by Pretransplant Donor Treatment with Immunomodulators. Biology of Blood and Marrow Transplantation. 15(4). 406–415. 5 indexed citations

Panigrahi, Soumya, et al.. (2004). A novel approach for prevention of lethal GVHD by selective elimination of alloreactive donor lymphocytes prior to stem cell transplantation. Experimental Hematology. 32(8). 756–764. 9 indexed citations

Morecki, Shoshana, et al.. (2004). Effect of KRN7000 on induced graft-vs-host disease. Experimental Hematology. 32(7). 630–637. 33 indexed citations

Prigozhina, Tatyana B., et al.. (2003). CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cells. Experimental Hematology. 31(1). 81–88. 10 indexed citations

Slavin, Shimon, Shoshana Morecki, Lola Weiss, & Reuven Or. (2002). Donor Lymphocyte Infusion: The Use of Alloreactive and Tumor-Reactive Lymphocytes for Immunotherapy of Malignant and Nonmalignant Diseases in Conjunction with Allogeneic Stem Cell Transplantation. Journal of Hematotherapy & Stem Cell Research. 11(2). 265–276. 40 indexed citations

Panigrahi, Soumya, et al.. (2002). Intraportal and systemic allogeneic cell therapy in a murine model of hepatic metastatic breast cancer. PubMed. 7(3). 99–106. 4 indexed citations

Morecki, Shoshana & Shimon Slavin. (2000). Toward Amplification of a Graft-Versus-Leukemia Effect While Minimizing Graft-Versus-Host Disease. Journal of Hematotherapy & Stem Cell Research. 9(3). 355–366. 15 indexed citations

Morecki, Shoshana, Yael Gelfand, Arnon Nagler, et al.. (1997). Activated Long-Term Peripheral Blood Cultures as Preparation for Adoptive Alloreactive Cell Therapy in Cancer Patients. Journal of Hematotherapy. 6(2). 115–124. 11 indexed citations

Morecki, Shoshana, P. Falk, Masha Fridkis‐Hareli, et al.. (1997). The Effect of Linomide, an Immunoregulator in Experimental Autoimmune Diseases, on Humoral Antibody Responses in Mice. Autoimmunity. 25(4). 223–232. 4 indexed citations

10.

Morecki, Shoshana, et al.. (1997). Induction of graft vs. tumor effect in a murine model of mammary adenocarcinoma. International Journal of Cancer. 71(1). 59–63. 54 indexed citations

11.

Morecki, Shoshana, et al.. (1995). Induction of tumor immunity by intact irradiated leukemic B cells (BCL1) bearing a tumor-associated cell-surface idiotype and the costimulatory B7 molecule. Cancer Immunology Immunotherapy. 41(4). 236–242. 4 indexed citations

12.

Morecki, Shoshana, Shoshana Revel‐Vilk, Marjorie Pick, et al.. (1992). Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-α2a and interleukin-2. Cancer Immunology Immunotherapy. 35(6). 401–411. 20 indexed citations

13.

Morecki, Shoshana, Evelyn M. Karson, Kenneth Cornetta, et al.. (1991). Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells. Cancer Immunology Immunotherapy. 32(6). 342–352. 28 indexed citations

14.

Morecki, Shoshana, et al.. (1991). The effect of in vitro T lymphocyte depletion on generation of IL2-activated cytotoxic cells.. PubMed. 7(4). 269–73. 6 indexed citations

15.

Morecki, Shoshana & S Slavin. (1989). Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation.. PubMed. 24(9-10). 488–93. 5 indexed citations

16.

Morecki, Shoshana, Shlomo Margel, & Shimon Slavin. (1988). Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrow.. PubMed. 48(16). 4573–7. 12 indexed citations

17.

Slavin, Shimon, Herman Waldmann, Reuven Or, et al.. (1985). PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION. Transplantation Proceedings. 17. 465–467. 21 indexed citations

18.

Yatziv, S, et al.. (1982). Long-term enzyme replacement therapy in beta-glucuronidase--deficient mice by allogeneic bone marrow transplantation.. PubMed. 99(6). 792–7. 8 indexed citations

19.

Slavin, S, Shoshana Morecki, & Lola Weiss. (1980). The role of the spleen in tumor growth kinetics of the murine B cell leukemia (BCL1).. The Journal of Immunology. 124(2). 586–589. 15 indexed citations

20.

Naor, David, Shoshana Morecki, & Eli Kedar. (1973). Differential Induction and Suppression of Direct and Indidirect PFC Responses to TNP Conjugated to Heterologous Erythrocytes. Advances in experimental medicine and biology. 29(0). 225–232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact